Christopher Power Selected Research

syncytin

11/2011	Neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration.
4/2011	Age- and disease-dependent HERV-W envelope allelic variation in brain: association with neuroimmune gene expression.
2/2011	Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?
7/2007	The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes.
10/2004	Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher Power Research Topics

Disease

30	Neuroinflammatory Diseases 12/2021 - 02/2004
29	Infections 12/2021 - 06/2003
23	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 11/2004
18	Multiple Sclerosis 01/2021 - 03/2003
12	Inflammation (Inflammations) 01/2021 - 03/2003
11	HIV Infections (HIV Infection) 12/2021 - 10/2003
9	Nervous System Diseases (Neurological Disorders) 01/2020 - 12/2004
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019 - 06/2005
7	Lentivirus Infections 05/2014 - 07/2005
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2007
6	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 02/2004
5	Gliosis 05/2017 - 01/2004
4	Neurocognitive Disorders (Clerambault Syndrome) 01/2021 - 11/2015
4	Coinfection 01/2020 - 04/2009
4	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 03/2003
4	Zika Virus Infection 01/2019 - 12/2016
3	Brain Diseases (Brain Disorder) 08/2014 - 06/2003
3	Atrophy 11/2011 - 03/2006
3	Peripheral Nervous System Diseases (PNS Diseases) 11/2011 - 10/2006
3	Dementia (Dementias) 06/2011 - 06/2005
2	Huntington Disease (Huntington's Disease) 01/2022 - 12/2004
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2004
2	Cognitive Dysfunction 01/2021 - 10/2006
2	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 05/2017
2	Neuralgia (Stump Neuralgia) 01/2021 - 11/2010
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2016
2	Neoplasms (Cancer) 09/2019 - 06/2005
2	Alzheimer Disease (Alzheimer's Disease) 02/2014 - 10/2007
2	Stroke (Strokes) 02/2014 - 12/2004
2	Central Nervous System Diseases (CNS Diseases) 01/2014 - 08/2008
2	Superinfection 04/2009 - 04/2005
2	AIDS Dementia Complex 03/2007 - 08/2005
1	Shock 12/2021
1	COVID-19 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Rupture 08/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Frailty 01/2020

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2003
9	Pharmaceutical PreparationsIBA 01/2021 - 10/2003
7	Antiviral Agents (Antivirals)IBA 01/2021 - 10/2016
7	CytokinesIBA 10/2019 - 04/2005
7	InflammasomesIBA 09/2019 - 12/2013
6	Peptide Hydrolases (Proteases)FDA Link 10/2019 - 01/2004
6	MicroRNAs (MicroRNA)IBA 12/2018 - 06/2010
6	Neuroprotective AgentsIBA 03/2018 - 09/2009
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2016 - 04/2005
5	InterferonsIBA 11/2018 - 11/2010
5	Messenger RNA (mRNA)IBA 11/2015 - 03/2003
5	syncytinIBA 11/2011 - 10/2004
4	RNA (Ribonucleic Acid)IBA 01/2018 - 08/2005
4	Proteinase-Activated ReceptorsIBA 11/2011 - 01/2004
4	Glycoproteins (Glycoprotein)IBA 11/2011 - 10/2004
3	Biomarkers (Surrogate Marker)IBA 12/2018 - 02/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2017
3	NeurosteroidsIBA 10/2017 - 09/2011
3	vpr Gene ProductsIBA 01/2017 - 09/2010
3	Thrombin FDA Link 11/2015 - 03/2003
3	Viral ProteinsIBA 06/2012 - 01/2006
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2011 - 03/2003
2	NucleosidesIBA 01/2021 - 01/2016
2	NucleotidesIBA 01/2021 - 01/2016
2	Caspase 3 (Caspase-3)IBA 01/2021 - 08/2020
2	belnacasanIBA 01/2021 - 01/2017
2	Free RadicalsIBA 10/2019 - 02/2011
2	Matrix Metalloproteinases (MMPs)IBA 03/2018 - 06/2003
2	ChemokinesIBA 01/2018 - 10/2003
2	Insulin (Novolin)FDA Link 01/2018 - 10/2016
2	Dehydroepiandrosterone (DHEA)IBA 10/2017 - 02/2013
2	InterleukinsIBA 10/2017 - 11/2015
2	EnzymesIBA 10/2017 - 09/2011
2	AntigensIBA 01/2017 - 05/2013
2	Protease Inhibitors (Protease Inhibitor)IBA 02/2016 - 05/2006
2	PAR-1 ReceptorIBA 11/2015 - 03/2003
2	Pregnanolone (Allopregnanolone)IBA 01/2014 - 09/2011
2	Carisoprodol (Soma)FDA LinkGeneric 11/2011 - 03/2006
2	CalciumIBA 11/2011 - 11/2010
2	Peptides (Polypeptides)IBA 11/2011 - 03/2003
2	AntioxidantsIBA 02/2011 - 10/2004
2	Interleukin-1beta (Interleukin 1 beta)IBA 05/2010 - 05/2003
2	Interleukin-4 (Interleukin 4)IBA 05/2010 - 10/2007
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2008 - 02/2004
2	Glial Fibrillary Acidic ProteinIBA 10/2007 - 07/2007
2	Didanosine (Videx)FDA LinkGeneric 08/2007 - 05/2006
2	LigandsIBA 06/2005 - 01/2004
1	GangliosidesIBA 01/2022
1	Viral RNAIBA 12/2021
1	CuprizoneIBA 01/2021
1	NickelIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Adenosine Triphosphate (ATP)IBA 08/2020
1	Small Interfering RNA (siRNA)IBA 08/2020
1	NigericinIBA 08/2020
1	Peptidoglycan (Murein)IBA 01/2020
1	CateninsIBA 01/2020

Therapy/Procedure

15	Therapeutics 12/2021 - 04/2005
9	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 08/2005
4	Art Therapy 12/2021 - 10/2017
3	Polypharmacy 01/2021 - 01/2016